# Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 amending Regulation (EU) No 37/2010 as regards the substance gamithromycin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRLs
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Gamithromycin
Gamithromycin
All ruminants except bovine
50 μg/kg
Muscle
Not for use in animals producing milk for human consumption
Anti-infectious agents/Antibiotics’
50 μg/kg
Fat
300 μg/kg
Liver
200 μg/kg
Kidney
Bovine
20 μg/kg
Fat
200 μg/kg
Liver
100 μg/kg
Kidney
Porcine
100 μg/kg
Muscle
NO ENTRY
100 μg/kg
Skin and fat in natural proportions
100 μg/kg
Liver
300 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2016/2045/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-2045/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.